Jump to content

User:CommonPeruvian/sandbox

From Wikipedia, the free encyclopedia
This is an old revision of this page, as edited by CommonPeruvian (talk | contribs) at 04:06, 7 December 2024. The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
Américo Garibaldi Ghersi
BornJanuary 15, 1893
Ilo, Moquegua, Peru
DiedDecember 21, 1938 (aged 45)
New York City, United States
CitizenshipPeru
Alma mater
SpouseRosa Flores Córdoba
Children4
Scientific career
Fields
Thesis Thyroid insufficiency and immunity

Américo Garibaldi Ghersi was a Peruvian scientist known mainly for his extensive research and contributions in the study of cancer and malaria.

He presented a new theory on endocrine allergy to the Académie des Sciences, which was published in its bulletin.

Early life and education

Américo Garibaldi Ghersi was born on January 15th 1893, in Ilo, a port city located in the department of Moquegua in southern Peru, to Gaetano Garibaldi, an Italian merchant, and Rosa Ghersi.

He completed his primary and secondary education in Lima, Peru. He enrolled at the Faculty of Science at the National University of San Marcos, completing his studies there in 1909. After this, he paused his studies and traveled to France in 1913.

That same year, in France, he studied at the Sorbonne University in Paris. In 1919, Garibaldi entered the Faculty of Medicine in Paris, from where he graduated as a Bachelor of Medicine in 1923, with the thesis "Thyroid insufficiency and immunity", which won him the faculty's thesis medal.

Career

In 1923, Garibaldi began to work at the laboratory of experimental pathology of Georges Henri Roger, dean of the Faculty of Medicine; the experimental physiology research laboratory of professor Charles Richet; and the laboratory of experimental biology at the Collège de France.

In 1925, upon returning to Peru, Garibaldi revalidated his academic title at the Faculty of Medicine "San Fernando" at the National University of San Marcos. Where he was appointed head of Pharmacology and Pathophysiology. Garibaldi introduced a new procedure for the serological diagnosis of pregnancy and cancer, which was presented at the Third Pan-American Scientific Congress, and earned him his Doctorate in 1931.

Between 1932 and 1934, he traveled to Europe to study malaria, working at the Institute of Exotic Pathology in Paris and the Malariology Institute in Rome. During this period, he developed a new method for malaria treatment, published in 1935.

In 1936, he was commissioned by the Peruvian government to investigate cancer in the United States. He worked in New York under the auspices of the Rockefeller Institute, where he discovered a vaccine capable of immunizing against certain cancerous tumors. His achievements earned him membership at Fordham University, making him the first oncologist to be inducted into the institution. To further his cancer research, the Westinghouse company provided him with a specially designed radiotherapy apparatus.

Ghersi passed away in New York on December 21, 1938, at the age of 45, while working to perfect the anticancer vaccine he had discovered.

Works

Entre sus principales trabajos de investigación científica se citan: “Influencia de la tiro paratiroidectomía sobre la formación de anticuerpos naturales-dosaje del poder heterobremolítico del suero (Paris, 1920); “La alergia tiroidea (Paris, 1923); “Principios y Técnicas de un nuevo método general del sero diagnóstico” (1925); “La inmunidad antipalúdica. Proyecciones terapéuticas y medicosociales del problema (1935); “Mecanismo probable de la cancerización” (1936). Dejó inconcluso “La inmunoterapia del cáncer a la luz del análisis fisiopatológico y farmacodinámico”.

Personal life

In 1930, Lima, Peru, Garibaldi married Rosa Flores Córdoba, with whom he had 4 children: Gaetano, Rosa, Pablo, and Américo.

Honors

  • I.E. Americo Garibaldi Ghersi school in Pacocha, Ilo, Peru was named in his honor.[1]

References

  1. ^ "Identicole" (in Spanish). Ministerio de Educacion del Peru. Retrieved December 6, 2024.{{cite web}}: CS1 maint: url-status (link)